La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
M. Schulzer40
Canada Sauf M. Schulzer" 7473
M. Schulzer Sauf Canada" 5
Canada Et M. Schulzer 35
Canada Ou M. Schulzer 7513
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 35.
Ident.Authors (with country if any)Title
001E02 A R Troiano [Canada] ; R. De La Fuente-Fernandez ; V. Sossi ; M. Schulzer ; E. Mak ; T J Ruth ; A J StoesslPET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
001E89 R. Nandhagopal [Canada] ; L. Kuramoto [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; J. Cragg [Canada] ; Chong S. Lee [Canada] ; J. Mckenzie [États-Unis] ; S. Mccormick [Canada] ; A. Samii [États-Unis] ; A. Troiano [Canada] ; T. J. Ruth [Canada] ; V. Sossi [Canada] ; R. De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. J. Stoessl [Canada]Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
002072 A. R. Troiano [Canada] ; R. De La Fuente-Fernandez [Canada] ; V. Sossi [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; T. J. Ruth [Canada] ; A. J. Stoessl [Canada]PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
002385 R. Nandhagopal [Canada] ; E. Mak [Canada] ; M. Schulzer [Canada] ; J. Mckenzie [Canada] ; S. Mccormick [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; A. Strongosky [États-Unis] ; M. J. Farrer [États-Unis] ; Z. K. Wszolek [États-Unis] ; A. J. Stoessl [Canada]Progression of dopaminergic dysfunction in a LRRK2 kindred : A multitracer PET study
002D58 B C L. Lai [Canada] ; M. Schulzer ; S. Marion ; K. Teschke ; J K C. TsuiThe prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
002D81 J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B CalneFamilial and sporadic Parkinson's disease usually display the same clinical features.
003113 C R Honey [Canada] ; C. Berk ; R S Palur ; M. SchulzerMicroelectrode recording for pallidotomy: mandatory, beneficial or dangerous?
003119 C C. Sanjiv [Canada] ; M. Schulzer ; E. Mak ; J. Fleming ; W R. W. Martin ; T. Brown ; S M. Calne ; J. Tsui ; A J. Stoessl ; C S. Lee ; D B. CalneDaytime somnolence in patients with Parkinson's disease.
003123 P K. Pal [Canada] ; C S. Lee ; A. Samii ; M. Schulzer ; A J. Stoessl ; E K. Mak ; J. Wudel ; T. Dobko ; J K. C. TsuiAlternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET
003246 C. C Sanjiv [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; J. Fleming [Canada] ; W. R. W Martin [Canada] ; T. Brown [Canada] ; S. M Calne [Canada] ; J. Tsui [Canada] ; A. J Stoessl [Canada] ; C. S Lee [Canada] ; D. B Calne [Canada]Daytime somnolence in patients with Parkinson's disease
003263 P. K. Pal [Canada] ; C. S. Lee [Canada] ; A. Samii [Canada] ; M. Schulzer [Canada] ; A. J. Stoessl [Canada] ; E. K. Mak [Canada] ; J. Wudel [Canada] ; T. Dobko [Canada] ; J. K. C. Tsui [Canada]Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki
003476 P K Pal [Canada] ; A. Samii [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; I M Turnbull [Canada] ; D B Calne [Canada]Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years
003585 R. De La Fuente-Fernandez [Canada] ; P. K. Pal [Canada] ; F. J. G. Vingerhoets [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; T. J. Ruth [Canada] ; B. J. Snow [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada]Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
003718 A. Samii [Canada] ; I. M. Turnbull [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada]Reassessment of unilateral pallidotomy in Parkinson's disease
003791 C. R. Honey [Canada] ; A. J. Stoessl [Canada] ; J. K. C. Tsui [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada]Unilateral pallidotomy for reduction of parkinsonian pain
003811 J. K. C. Tsui [Canada] ; D. B. Calne [Canada] ; YUE WANG [Canada] ; M. Schulzer [Canada] ; S. A. Marion [Canada]Occupational risk factors in Parkinson's disease
003883 R. De La Fuente-Fernandez [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; A. Kishore [Canada] ; D. B Calne [Canada]The role of the Lewy body in idiopathic Parkinsonism
003910 R. De La Fuente-Fernández [Canada] ; A. Kishore [Canada] ; B. J. Snow [Canada] ; M. Schulzer [Canada] ; C. S. Lee [Canada] ; T. J. Ruth [Canada] ; A. J. Stoessl [Canada]Effect of age on caudate dopaminergic function in idiopathic Parkinsonism
003A68 H. Shinotoh [Canada] ; F J Vingerhoets ; C S Lee ; R J Uitti ; M. Schulzer ; D B Calne ; J. TsuiLamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
003A70 H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B CalneFluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
003C59 A. Kishore [Canada] ; I. M. Turnbull [Canada] ; B. J. Snow [Canada] ; R. De La Fuente-Fernandez [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada]Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease: Six-month follow-up with additional 1-year observations
003C78 R. J. Uitti [Canada] ; H. Shinotoh [Canada] ; M. Hayward [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]"Familial Parkinson's disease": A case-control study of families
003C84 A. Kishore [Canada] ; Z K Wszolek ; B J Snow ; R. De La Fuente-Fernandez ; F. Arwert ; M. Wijker ; M. Schulzer ; D B Calne ; F J VingerhoetsPresynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.
003D04 S. Calne [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; C. Guyette [Canada] ; G. Rohs [Canada] ; S. Hatchard [Canada] ; D. Murphy [Canada] ; J. Hodder [Canada] ; C. Gagnon [Canada] ; S. Weatherby [Canada] ; L. Beaudet [Canada] ; J. Duff [Canada] ; S. Pegler [Canada]Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)
003E87 F. J. G. Vingerhoets [Canada] ; M. Schulzer ; T. J. Ruth ; J. E. Holden ; B. J. SnowReproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease
004091 C. S. Lee [Canada] ; M. Schulzer ; E. Mak ; J. P. Hammerstad ; S. Calne ; D. B. CalnePatterns of asymmetry do not change over the course of idiopathic parkinsonism : implications for pathogenesis
004182 C. S. Lee [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; B. J. Snow [Canada] ; J. K. Tsui [Canada] ; S. Clane [Canada] ; J. Hammerstad [Canada] ; D. B. Clane [Canada]Clinical observations on the rate of progression of idiopathic parkinsonism
004187 M. Schulzer [Canada] ; C. S. Lee [Canada] ; E. K. Mak [Canada] ; F. J. G. Vingerhoets [Canada] ; D. B. Calne [Canada]A mathematical model of pathogenesis in idiopathic parkinsonism
004207 J. P. Hammerstad [Canada] ; K. Elliott [Canada] ; E. Mak [Canada] ; M. Schulzer [Canada] ; S. Calne [Canada] ; D. B. Calne [Canada]Tendon jerks in Parkinson's disease
004224 F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud [États-Unis] ; J. W. Langston [États-Unis] ; M. Schulzer [Canada] ; M. Calne [Canada]Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
004243 F. J. G. Vingerhoets [Canada] ; F. J. G. Snow [Canada] ; C. S. Lee [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism
004628 M. Schulzer [Canada] ; E. Mark ; D. B. CalneThe antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
004657 R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada]Cerebral glucose metabolism in Parkinson's disease with and without dementia
004679 A. Eisen [Canada] ; S. Siejka ; M. Schulzer ; D. CalneAge-dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson's disease.
005614 C. Schwab [Canada] ; M. Schulzer ; J C Steele ; P L McgeerOn the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022